Overexpression of mitochondrial ferritin sensitizes cells to oxidative stress via an iron-mediated mechanism

Antioxidants and Redox Signaling

Volumn 11, Issue 8, 2009, Pages 1791-1803

  Lu, Zhongbing ^a   Nie, Guangjun ^b   Li, Yiye ^b   Soe lin, Shan ^c   Tao, Yi ^a   Cao, Yuanlin ^a   Zhang, Zhiyong ^d   Liu, Nianqing ^d   Ponka, Prem ^c   Zhao, Baolu ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FERRITIN; GLUTATHIONE; ISONIAZID DERIVATIVE; MITOCHONDRIAL FERRITIN; MITOCHONDRIAL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IRON METABOLISM; IRON TRANSPORT; MITOCHONDRIAL RESPIRATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ALDEHYDES; APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DEFEROXAMINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRITINS; HOMEOSTASIS; HUMANS; HYDRAZONES; IRON CHELATING AGENTS; LYSOSOMES; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TERT-BUTYLHYDROPEROXIDE;

EID: 67650229951     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2306     Document Type: Article

References (57)

1. Arosio P and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radio Biol Med 33: 457-463, 2002.
2. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, and Vercellotti GM. Ferritin: A cytoprotective antioxidant strategem of endothelium. J Biol Chem 267: 18148-18153, 1992.
3. Bottomley SS. Congenital sideroblastic anemias. Curr He-matol Rep 5: 41-49, 2006.
4. 2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276: 19738-19745, 2001.
5. Campanella A, Isaya G, O'Neill HA, Santambrogio P, Cozzi A, Arosio P, and Levi S. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast. Hum Mol Genet 13: 2279-2288, 2004.
6. Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E, Rolandi V, Biasiotto G, Drysdale J, and Arosio P. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 101: 1996-2000, 2003.
7. Corsi B, Cozzi A, Arosio P, Drysdale J, Santambrogio P, Campanella A, Biasiotto G, Albertini A, and Levi S. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem 277:22430-22437, 2002.
8. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: In vivo role of ferritin ferrox-idase activity. J Biol Chem 275: 25122-25129, 2000.
9. Dalton TP, Chen Y, Schneider SN, Nebert DW, and Shertzer HG. Genetically altered mice to evaluate glutathione ho-meostasis in health and disease. Free Radic Biol Med 37: 1511-1526, 2004.
10. De D, I, McVey WD, and Kaplan J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72-81, 2008.
11. Drysdale J, Arosio P, Invernizzi R, Cazzola M, Volz A, Corsi B, Biasiotto G, and Levi S. Mitochondrial ferritin: a new player in iron metabolism. Blood Cells Mol Dis 29: 376-383, 2002.
12. Eaton JW and Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32: 833-840, 2002.
13. Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C, and Cabantchik ZI. H-ferritin subunit over-expression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94: 3593-3603, 1999.
14. Fleming MD. The genetics of inherited sideroblastic anemias. Semin Hematol 39: 270-281, 2002.
15. Hall R and Losowsky MS. The distribution of erythroblast iron in sideroblastic anaemias. Br J Haematol 12: 334-340, 1966.
16. Hallaway PE, Eaton JW, Panter SS, and Hedlund BE. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci USA 86: 10108-10112, 1989.
17. Harrison PM and Arosio P. The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
18. Hofmann WK and Koeffler HP. Myelodysplastic syndrome. Annu Rev Med 56: 1-16, 2005.
19. Kadiiska MB, Burkitt MJ, Xiang QH, and Mason RP. Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation. J Clin Invest 96:1653-1657, 1995.
20. Kakhlon O, Gruenbaum Y, and Cabantchik ZI. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 97: 2863-2871, 2001.
21. Kotamraju S, Tampo Y, Keszler A, Chitambar CR, Joseph J, Haas AL, and Kalyanaraman B. Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endo-thelial cells: Role of ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 100: 10653-10658, 2003.
22. Kurz T, Leake A, Von Zglinicki T, and Brunk UT. Re-localized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 378: 1039-1045, 2004.
23. Langlois dB, Santambrogio P, Granier T, Gallois B, Chevalier JM, Precigoux G, Levi S, and Arosio P. Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala. J Mol Biol 340: 277-293, 2004.
24. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, Arosio P, and Drysdale J. A human mitochondrial ferritin encoded by an intronless gene. JBiol Chem 276: 24437-24440, 2001.
25. Lill R and Muhlenhoff U. Iron-sulfur protein biogenesis in eukaryotes: Components and mechanisms. Annu Rev Cell Dev Biol 22: 457-486, 2006.
26. May A and Fitzsimons E. Sideroblastic anaemia. Baillieres Clin Haematol 7: 851-879, 1994.
27. Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abe-cassis J, Millon R, and Merlin JL. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer 83: 1380-1386, 2000.
28. Missirlis F, Holmberg S, Georgieva T, Dunkov BC, Rouault TA, and Law JH. Characterization of mitochondrial ferritin in Drosophila. Proc Natl Acad Sci USA 103: 5893-5898, 2006.
29. Napier I, Ponka P, and Richardson DR. Iron trafficking in the mitochondrion: Novel pathways revealed by disease. Blood 105: 1867-1874, 2005.
30. Nie G, Chen G, Sheftel AD, Pantopoulos K, and Ponka P. In vivo tumor growth is inhibited by cytosolic iron deprivation caused by the expression of mitochondrial ferritin. Blood 108:2428-2434, 2006.
31. Nie G, Sheftel AD, Kim SF, and Ponka P. Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis. Blood 105: 2161-2167,2005.
32. Orino K, Tsuji Y, Torti FM, and Torti SV. Adenovirus E1A blocks oxidant-dependent ferritin induction and sensitizes cells to pro-oxidant cytotoxicity. FEBS Lett 461: 334-338, 1999.
33. Pandolfo M. Iron and Friedreich ataxia. J Neural Transm Suppl 143-146, 2006.
34. Pantopoulos K and Hentze MW. Activation of iron regulatory protein-1 by oxidative stress in vitro. Proc Natl Acad Sci USA 95: 10559-10563, 1998.
35. Persson HL, Kurz T, Eaton JW, and Brunk UT. Radiation-induced cell death: importance of lysosomal destabilization. Biochem J 389: 877-884, 2005.
36. Persson HL and Richardson DR. Iron-binding drugs targeted to lysosomes: A potential strategy to treat inflammatory lung disorders. Expert Opin Investig Drugs 14: 997-1008, 2005.
37. Persson HL, Yu Z, Tirosh O, Eaton JW, and Brunk UT. Prevention of oxidant-induced cell death by lysosomotropic iron chelators. Free Radic Biol Med 34: 1295-1305, 2003.
38. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells. Blood 89: 1-25, 1997.
39. Ponka P, Borova J, Neuwirt J, Fuchs O, and Necas E. A study of intracellular iron metabolism using pyridoxal iso-nicotinoyl hydrazone and other synthetic chelating agents. Biochim Biophys Acta 586: 278-297, 1979.
40. Ponka P and Schulman HM. Acquisition of iron from transferrin regulates reticulocyte heme synthesis. J Biol Chem 260: 14717-14721, 1985.
41. Radisky DC and Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J 336: 201-205, 1998.
42. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE, and Geilen CC. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333-340, 2001.
43. Richardson DR and Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neo-plastic cells. Biochim Biophys Acta 1331: 1-40, 1997.
44. Roberg K, Johansson U and Ollinger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 27: 1228-1237, 1999.
45. Roberg K and Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apo-ptosis in neonatal rat cardiomyocytes. Am J Pathol 152: 11511156, 1998.
46. Rouault TA and Tong WH. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol 6:345-351, 2005.
47. Santambrogio P, Biasiotto G, Sanvito F, Olivieri S, Arosio P, and Levi S. Mitochondrial ferritin expression in adult mouse tissues. J Histochem Cytochem 55: 1129-1137, 2007.
48. Sekeres MA. The myelodysplastic syndromes. Expert Opin Biol Ther 7: 369-377, 2007.
49. Sheftel AD, Zhang AS, Brown C, Shirihai OS, and Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110: 125-132, 2007.
50. Srigiridhar K and Nair KM. Iron-deficient intestine is more susceptible to peroxidative damage during iron supplementation in rats. Free Radic Biol Med 25: 660-665, 1998.
51. Tehranchi R, Invernizzi R, Grandien A, Zhivotovsky B, Fa-deel B, Forsblom AM, Travaglino E, Samuelsson J, Hast R, Nilsson L, Cazzola M, Wibom R, and Hellstrom-Lindberg E. Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes. Blood 106: 247-253, 2005.
52. Theil EC, Matzapetakis M, and Liu X. Ferritins: Iron/oxygen biominerals in protein nanocages. J Biol Inorg Chem 11: 803-810, 2006.
53. Torti FM and Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
54. Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, and Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20: 5818-5827, 2000.
55. Vessey DA, Lee KH, Blacker KL. Characterization of the oxidative stress initiated in cultured human keratino-cytes by treatment with peroxides. J Invest Dermatol 99: 859-863, 1992.
56. Zanella I, Derosas M, Corrado M, Cocco E, Cavadini P, Bia-siotto G, Poli M, Verardi R, and Arosio P. The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. Biochim Biophys Acta 1782: 90-98, 2008.
57. Zhang Y and Zhao B. Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuro-blastoma SH-SY5Y cells. J Neurochem 86: 1189-1200, 2003.